$ADUR Third party testing shows recycled Hydrochemolytic™ oil from mixed plastics can directly substitute for naphtha from crude oil for the production of new plastic. Circularity! https://t.co/suddLTx4oi

$ADUR Aduro Validation https://t.co/UMOxEj9LgN

1/ I usually don’t respond to comments like these, but there’s a lot of misinformation being repeated about $ADUR, $PCT, and the chemical recycling space in general. So here’s a detailed breakdown of why the “Aduro is a zero” narrative is not grounded in facts — and why Aduro is

$CRDL CEO David Elsley discusses the company's acute pericarditis program and the potential advantages of CardiolRx™ over current treatments, now in Phase III after a successful Phase II clinical trial. Also, look for full results from Phase II myocarditis trial soon.

This is the Biggest News in Aduro's History. This will shake up the Oil Industry. Starting today, Aduro Will Never be the Same. $ADUR https://t.co/I7hlHoidVK

Thread 🧵: Why today’s $ADUR news is a major inflection point for shareholders:

$ADUR | $ACT just passed the hardest test in circular plastics. 🧪🌊🌐 https://t.co/cnZiahSgaw 🏭 A global steam-cracking leader ran HCT oil as-produced — no hydrotreating, no dilution. Results: 💥 Stable furnace ops 💥 Ethylene/propylene yields on par with fossil feed 💥 Meets

4/4 … coupled with aggressive expansion. It's a fundamental story that investors should investigate. Take a look at $LEEEF Leef Brands and the progress the company has made in two of the premier legal cannabis markets in the world - California and New York.

3/ … roughly equal to its hard assets without taking into account annual revenues in the same neighborhood - with further growth expected. And after years of heavy investments into facilities, the company has moved into positive EBITDA driven by disciplined cost control…

2/ This company expects those figures to improve even further in the coming quarters as diversification into new lucrative markets and increasing operational efficiencies take hold. Meanwhile, its market cap of $40 million is…

1/ As small cap investors we are always looking for the undiscovered gem that is executing an effective growth strategy. How about an early mover working in an expanding industry that recently doubled its margins and boosted revenue 24% in its most recent quarter?

$AIRDF Rocket Doctor AI's acquisition is a big move into AI-driven mental health care and provides a foothold in the Middle East where governments are committed to advancing #DigitalHealth initiatives. Get the details:

📢 Save the date: The full ARCHER results will be presented during a live webcast and conference call on December 1 at 8:30 a.m. ET (UTC-5). 🔗 Register via our Events page: https://t.co/vZB2QQvObL This presentation will highlight important clinical findings with the potential

Since listing on the Nasdaq late last year, plastic recycling tech upstart $ADUR has been gaining the attention of institutional investors. With commercialization drawing closer, institutional ownership is up 15% in the last quarter. Read more. https://t.co/LqFtGpKcab

A look at the broad market-moving implications of tomorrow's highly anticipated earnings announcement from $NVDA. There will be action. Read more. https://t.co/fguxMTmMmg

Investor alert: Patents and market protections are expiring and big pharma is increasing M&A activities for later stage clinical assets in certain disease areas. Cardiovascular companies like $CRDL are well positioned. Read more. https://t.co/8j6Md4vXGL

We're teaming with $AIRDF to bring you the story of an AI-driven telehealth platform gaining momentum across North America. The path from first revenue to market penetration... details here. https://t.co/8wwiydzi81

It's a big week in retail earnings with $HD $LOW $TGT $WMT $ROST $WSM all set to report. Get the lowdown here with a review for investors. https://t.co/INCfrFbi7V

Excited to announce that we will be featured on @EarthWithJohnH this month. We are also presenting at key global events: @novaInstitut's #AdvancedRecyclingConference2025 in Germany, and @CMTconferences's #FlexPackLATAM in Mexico. 🔗 https://t.co/qqDOYCvj29 $ADUR #CleanTech #Earth

Big news for $CRDL, broad IP protection like this is very important for Cardiol investigating and showing promise in a range of heart conditions including heart failure, pericarditis, and myocarditis.